The objectives of this study were to determine the effectiveness, side effects, and
acceptability of one-third the standard 600 mg dose of mifepristone (200 mg) to induce …

Objectives. Medical abortion was first introduced in Norway in April 1998. The aims of this
study were to assess the efficacy, side effects, and acceptability of medical abortion using …

BACKGROUND: Nonsurgical abortion methods have the potential to improve access to high-
quality abortion care. Until recently, availability and utilization of mifepristone medical …

Background Medical termination of pregnancy can be successfully performed with a
combination of mifepristone (RU 486) and a prostaglandin analogue. We conducted a …

INTRODUCTION: In the interest of decreasing the amount of time it takes to achieve a
medical abortion, we performed a pilot study to evaluate the simultaneous administration of …

HYPOTHESIS: Simultaneous administration of mifepristone and misoprostol for medical
abortion in women up to 49 days gestation will result in complete abortion in 90% of women …

Aim To compare the efficacy of different intervals of misoprostol administration
(simultaneously vis-à-vis 24 h), after mifepristone, in women undergoing medical termination …

It is known that when misoprostol is given at 200 μg every 3 h after mifepristone
pretreatment, the vaginal route is more effective than the oral route. However, women prefer …

Background Mifepristone, followed 48 hours later by administration of misoprostol, is a well-
established regimen for medical termination of pregnancy (TOP). Although this regimen is …

OBJECTIVE: Mifepristone–misoprostol medical abortion has been approved in the United
States since 2000. US providers have preferred to use vaginal misoprostol because of …